Trial Profile
A Phase 1, Single-ascending-dose Study to Evaluate the Safety and Pharmacokinetics of MEDI0382 in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Aug 2021
Price :
$35
*
At a glance
- Drugs Cotadutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; First in man
- Sponsors MedImmune
- 01 Aug 2021 Results assessing the safety and pharmacokinetics of cotadutide in phase 1 (n=32; 24 Japanese and 8 Chinese healthy adults) and phase 2 (n=61 Japanese adults) trials in overweight or obese participants of Asian descent with or without type 2 diabetes, published in the Diabetes, Obesity and Metabolism.
- 12 Jun 2018 Results (n=48) published in the British Journal of Clinical Pharmacology.
- 08 Sep 2015 Status changed from not yet recruiting to completed as per ClinicalTrials.gov record.